Astex Pharmacaeuticals Revenue and Competitors
Estimated Revenue & Valuation
- Astex Pharmacaeuticals's estimated annual revenue is currently $75M per year.
- Astex Pharmacaeuticals's estimated revenue per employee is $675,676
Employee Data
- Astex Pharmacaeuticals has 111 Employees.
- Astex Pharmacaeuticals grew their employee count by -33% last year.
Astex Pharmacaeuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | CPA, VP, Finance | Reveal Email/Phone |
2 | CSO | Reveal Email/Phone |
3 | SVP Medicinal Chemistry | Reveal Email/Phone |
4 | VP, Quality Assurance & Compliance | Reveal Email/Phone |
5 | SVP, Corporate Development; Head Business Development | Reveal Email/Phone |
6 | VP Finance & Admin | Reveal Email/Phone |
7 | Head Human Resources | Reveal Email/Phone |
8 | SVP Informatics | Reveal Email/Phone |
9 | SVP, Head Chemistry | Reveal Email/Phone |
10 | VP Chemistry | Reveal Email/Phone |
Astex Pharmacaeuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Astex Pharmacaeuticals?
Based in Dublin, California, SuperGen is a pharmaceutical company dedicated to the development and commercialization of products intended to treat life-threatening diseases, particularly cancer.
keywords:N/AN/A
Total Funding
111
Number of Employees
$75M
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Astex Pharmacaeuticals News
2022-04-17 - Fragment-Based Drug Discovery Market Research Report 2022 ...
Fragment-Based Drug Discovery Market Research Report 2022| Astex Pharmaceuticals, Alveus Pharmaceuticals Pvt. Ltd, Beactica AB.
2022-04-13 - Introducing Clinical Trial Updates | Journal of Clinical Oncology
Research Funding: Taiho Pharmaceutical (Inst), Novartis (Inst), Seattle Genetics (Inst), Pfizer (Inst), Astex Pharmaceuticals (Inst),...
2022-03-30 - Race Oncology inks supply agreement with Astex Pharmaceuticals to supply ASTX727 for cancer drug Zantrene"s trials
Race Oncology inks supply agreement with Astex Pharmaceuticals to supply ASTX727 for cancer drug Zantrene's trials.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $20M | 111 | 8% | N/A |
#2 | $28.4M | 112 | 13% | N/A |
#3 | $11.3M | 113 | -3% | N/A |
#4 | $300M | 113 | -6% | $77.9M |
#5 | $18.1M | 113 | 102% | N/A |